Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY -2.61%66 Days Payable is 26.46 as of Mar. 2026, which is 9% above its 10-year median of 24.27. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Surgery Partners ranks worse than 78.68% on this metric.
The historical rank and industry rank for Surgery Partners's Days Payable or its related term are showing as below:
SGRY'
s Days Payable Range Over the Past 10 Years
Min: 21.14 Med: 24.27 Max: 29.95
Current: 25.23
During the past 13 years, Surgery Partners's highest Days Payable was 29.95. The lowest was 21.14. And the median was 24.27.
SGRY's Days Payable is ranked worse than 78.68% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs SGRY: 25.23
Surgery Partners's Days Payable
declined
from Mar. 2025 (27.76) to Mar. 2026 (26.46).
It may suggest that Surgery Partnersaccelerated paying its suppliers.
The historical data trend for Surgery Partners's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Days Payable distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Surgery Partners's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a Days Payable of 26.46 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgery Partners and its competitors. This is near median its historical median of 24.27. Over the past decade, Surgery Partners' Days Payable has ranged from 21.14 to 29.95. According to the industry distribution chart, Surgery Partners ranks #476 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 78.7%.
Is Surgery Partners' Days Payable too high?
Surgery Partners' current Days Payable of 26.46 is near median its 10-year median of 24.27. Over the past 10 years, this metric has ranged from a low of 21.14 to a high of 29.95. The Healthcare Providers & Services industry median Days Payable is 56.95. Surgery Partners' value of 26.46 is 53.5% below this industry median. Based on the distribution chart, Surgery Partners ranks #476 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Days Payable compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #476 out of 605 companies for Days Payable. This places Surgery Partners in the lower half of its industry. The industry median Days Payable is 56.95. Surgery Partners' value of 26.46 is 53.5% below this benchmark. Historically, Surgery Partners' own Days Payable has ranged from 21.14 to 29.95 over the past decade. While the company's 10-year median is 24.27 vs. the industry median of 56.95, Surgery Partners has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current Days Payable of 26.46 is 53.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current Days Payable is 26.46, which is near median its own 10-year median of 24.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current Days Payable is 26.46, which is near median its 10-year median of 24.27 and 53.5% below the Healthcare Providers & Services industry median of 56.95. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Surgery Partners (SGRY), the current Days Payable is 26.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
Days Payable: 26.46 (near median its 10-year median of 24.27)
GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
Industry Position: 53.5% below the Healthcare Providers & Services median (#476 of 605)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
